Farmaceutisch concern · Denemarken
LEO Pharma
Een concern van 16 bedrijven met 255 geneesmiddelen in 10 landen.
Concernstructuur
16 bedrijven in 12 landen
Je pagina wordt geladen…
Je pagina wordt geladen…
Farmaceutisch concern · Denemarken
Een concern van 16 bedrijven met 255 geneesmiddelen in 10 landen.
16 bedrijven in 12 landen
Eén gratis account voor de Prognia-apps: Ward om te studeren, Osler voor klinische antwoorden met hun bronnen, en het netwerk om je collega’s te vinden.
Prognia stelt concerns samen uit de namen die toezichthouders publiceren en uit koppelingen tussen bedrijven; het is geen officiële concernstructuur.
Alle geneesmiddelen van alle bedrijven in het concern, actuele eerst.
1–25 van 255
| Geneesmiddel | Werkzame stof | Land | Status | Toelating |
|---|---|---|---|---|
| ACTIVATED CHARCOAL225 mg · Capsule | Charcoal activated | Canada | In de handel | 1998 |
| ADBRY150mg/ml · Injectable | Tralokinumab | Verenigde Staten | In de handel | 2021 |
| Adbry300mg/2ml · Injection | Tralokinumab | Verenigde Staten | In de handel | 2024 |
| ADTRALZA300 mg / 2 ml · Solution | Tralokinumab | Canada | In de handel | 2024 |
| ADTRALZA150 mg / ml · Solution | Tralokinumab | Canada | In de handel | 2022 |
| Adtralza | Tralokinumab | EU (EMA) | Toegelaten | 2021 |
| ADTRALZASoluzione iniettabile | Tralokinumab | Italië | Toegelaten | |
| Adtralza 150 mg/ml, oplossing voor injectie in voorgevulde spuitOplossing voor injectie | Tralokinumab | Nederland | Toegelaten | 2021 |
| ADTRALZA 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA150 mg · Solución inyectable | Tralokinumab | Spanje | In de handel | 2021 |
| Adtralza 300 mg, oplossing voor injectie in voorgevulde penOplossing voor injectie | Tralokinumab | Nederland | Toegelaten | 2021 |
| ADTRALZA 300 MG SOLUCION INYECTABLE EN PLUMA PRECARGADA300 mg · Solución inyectable | Tralokinumab | Spanje | In de handel | 2023 |
| ADVANTANCrema | Metilprednisolona aceponato | Italië | Toegelaten | |
| ADVANTAN | Metilprednisolona aceponato | Brazilië | Toegelaten | 2020 |
| Advantan 1 mg/g kremakrema | Metilprednizolonaceponat | Kroatië | In de handel | 2019 |
| Advantan 1 mg/g mastmast | Metilprednizolonaceponat | Kroatië | In de handel | 2019 |
| ADVENTAN 1 mg/g CREMA0,1 g · Crema | Metilprednisolona aceponato | Spanje | In de handel | 1994 |
| ADVENTAN 1 mg/g EMULSION CUTANEA100 mg · Emulsión cutánea | Metilprednisolona aceponato | Spanje | In de handel | 1999 |
| ADVENTAN 1 mg/g POMADA0,1 g · Pomada | Metilprednisolona aceponato | Spanje | In de handel | 1994 |
| ADVENTAN 1 mg/g UNGÜENTO0,1 g · Pomada | Metilprednisolona aceponato | Spanje | In de handel | 1994 |
| ANZUPGO20 mg / g · Cream | Delgocitinib | Canada | In de handel | 2025 |
| ANZUPGOCrema | Delgocitinib | Italië | Toegelaten | |
| Anzupgo | Delgocitinib | EU (EMA) | Toegelaten | 2024 |
| ANZUPGO2% · Cream | Delgocitinib | Verenigde Staten | In de handel | 2025 |
| ANZUPGO 20 MG/G CREMA20 mg · Crema | Delgocitinib | Spanje | In de handel | 2024 |
| Anzupgo 20 mg/g crèmeCrème | Delgocitinib | Nederland | Toegelaten | 2024 |
Waar het geneesmiddelen registreert of maakt, en hoeveel daarvan actueel zijn.
| Land | Geneesmiddelen | Actueel | Vroeger | Bedrijven |
|---|---|---|---|---|
| Canada | 55 | 33 | 22 | BedrijvenAlle geneesmiddelen |
| Spanje | 43 | 38 | 5 | BedrijvenAlle geneesmiddelen |
| Saoedi-Arabië | 38 | 38 | 0 | BedrijvenAlle geneesmiddelen |
| Roemenië | 25 | 0 | 25 | BedrijvenAlle geneesmiddelen |
| Nederland | 24 | 24 | 0 | BedrijvenAlle geneesmiddelen |
| Italië | 22 | 22 | 0 | BedrijvenAlle geneesmiddelen |
| Brazilië | 18 | 13 | 5 | BedrijvenAlle geneesmiddelen |
| Verenigde Staten | 18 | 18 | 0 | BedrijvenAlle geneesmiddelen |
| Europese Unie (EMA) | 6 | 5 | 1 | BedrijvenAlle geneesmiddelen |
| Kroatië | 6 | 6 | 0 | BedrijvenAlle geneesmiddelen |
Ook geregistreerd in: Frankrijk, Singapore, Verenigd Koninkrijk
De ATC-groepen waartoe de meeste van zijn geneesmiddelen behoren, grootste eerst.
De werkzame stoffen in de meeste van zijn geneesmiddelen.
Hoe de registers de naam schrijven, genormaliseerd: zonder rechtsvorm, accenten en hoofdletters.
Samengesteld door Prognia uit de openbare geneesmiddelen- en bedrijfsregisters hieronder. Logo’s worden niet gebruikt.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licentie: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licentie: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licentie: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licentie: Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licentie: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licentie: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licentie: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licentie: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licentie: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licentie: BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licentie: Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licentie: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licentie: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licentie: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci-con-dettaglio-autorizzazioni/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:44.771040+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licentie: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licentie: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licentie: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licentie: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licentie: Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licentie: Creative Commons Attribution 4.0 International (CC BY 4.0)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licentie: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licentie: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licentie: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Meld een fout of vraag verwijdering aanCorrecties van het bedrijf zelf zijn welkom.
Houd de geneesmiddelen van LEO Pharma op Prognia juist, zie hoe zorgprofessionals ze gebruiken en beantwoord wat ze vragen. Een gesprek van 20 minuten, in het Engels.
Plan een gesprekBekende farmaceutische concerns, elk met al zijn bedrijven.
Gerangschikt naar hun aantal geneesmiddelen.